戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 employed antibiotic classes tetracycline and streptogramin.
2 nhibitor madumycin II, an alanine-containing streptogramin A antibiotic, in the context of a function
3                The synergy in the binding of streptogramins A and B appears to result from a reorient
4                                              Streptogramins A is a class of protein synthesis inhibit
5           The crystal structure of Vat(D), a streptogramin acetyltransferase from a human urinary iso
6 in resistance phenotype and is mediated by a streptogramin acetyltransferase.
7 itors, the coproduction of type A and type B streptogramins, and the coregulated production and indep
8                      The effect of the novel streptogramin antibiotic quinupristin/dalfopristin (syne
9                                              Streptogramin antibiotics are used clinically to treat m
10  this work will lead to the discovery of new streptogramin antibiotics that overcome previous limitat
11 ort a modular, scalable synthesis of group A streptogramin antibiotics that proceeds in 6-8 linear st
12 es resistance to macrolide, lincosamide, and streptogramin antibiotics.
13 asses such as aminocyclitols, phenicols, and streptogramins as treatment alternatives.
14 ed hypersensitivity to macrolide-lincosamide-streptogramin B (MLS(B)) antibiotics on strains either c
15 rains contained either macrolide-lincosamide-streptogramin B (MLSB) resistance genes encoded by erm(A
16 l target modification (macrolide-lincosamide-streptogramin B [MLSB] resistance; usually encoded by er
17                                              Streptogramin B analogs were designed that have an amide
18 target sites for macrolide, lincosamide, and streptogramin B antibiotics.
19 her antibiotics of the macrolide-lincosamide-streptogramin B group (MLS) is methylation of the 23S rR
20 ed antibiotics of the macrolide, ketolide or streptogramin B groups during 50 S subunit reconstitutio
21 ssibility of inducible macrolide-lincosamide-streptogramin B resistance (MLSBi).
22 stitutive or inducible macrolide-lincosamide-streptogramin B resistance phenotype (cMLS(B) or iMLS(B)
23 esistant (constitutive macrolide-lincosamide-streptogramin B resistance) demonstrated either a double
24 ing resistance to macrolide, lincosamide and streptogramin B type (MLS) antibiotics were previously i
25 e inducibly MLS (macrolide, lincosamide, and streptogramin B)-resistant organisms.
26 erring resistance to macrolides-lincosamides-streptogramin B, showing that differential inhibition of
27 red macrolides, lincosamides or analogues of streptogramin B.
28 tracycline, multidrug, macrolide-lincosamide-streptogramin, bacitracin, vancomycin, beta-lactam and a
29                                          The streptogramin class of antibiotics act to inhibit bacter
30  an L-lysine-derived pyridyl moiety found in streptogramin group B antibiotics that are used as part
31 oup A component of natural and semisynthetic streptogramin mixtures is a prerequisite for the strepto
32          The occurrence of resistance to the streptogramin quinupristin-dalfopristin in Enterococcus
33                       The combination of the streptogramins quinupristin and dalfopristin was approve
34              PCR was performed to detect the streptogramin resistance genes vatD, vatE, and vgbA and
35                                        Known streptogramin resistance genes were absent in the majori
36 ifampin, but inducible macrolide-lincosamide-streptogramin resistance in a subset of CA-MRSA could be
37 ptogramin mixtures is a prerequisite for the streptogramin resistance phenotype and is mediated by a
38 rans, M. tuberculosis (macrolide-lincosamide-streptogramin resistance protein, MLSRP), and B. anthrac
39 virginiamycin may increase the potential for streptogramin-resistant E. faecium infection in humans.
40  in constitutive resistance to Er and type B streptogramins (Sg), proving that SgR does not require t
41 omise as an alternative to glycopeptides and streptogramins to treat serious infections due to resist
42 fers resistance to the macrolide-lincosamide-streptogramin type B (MLS) antibiotics through the methy
43                          Since 1974, another streptogramin, virginiamycin, has been used at subtherap
44             New methods to chemically modify streptogramins would enable structural optimization to o

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。